CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CRVSCorvus Pharmaceuticals, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $11.52 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$969.07M
RECENT INSIDER TRADES
  • 2026-06-15 · Moore David Scott (Director) · BUY
  • 2026-05-20 · MILLER RICHARD A MD (President and CEO) · BUY
  • 2025-07-01 · Thompson Peter A. (Director) · SELL
  • 2025-07-01 · ORBIMED ADVISORS LLC (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders181
Shares held75,714,124
Value$1.03B
Percent of shares outstanding90.01%
As of quarter end2026-06-30
RECENT NEWS
  • Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Corvus Pharmaceuticals, Inc. (CRVS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit